Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
14.37
+0.03 (0.21%)
At close: Mar 9, 2026, 4:00 PM EDT
14.38
+0.01 (0.07%)
After-hours: Mar 9, 2026, 6:45 PM EDT
Amicus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 4,512 | 4,405 | 2,815 | 4,161 | 3,430 | 3,218 | |
| Market Cap Growth | 65.76% | 56.48% | -32.36% | 21.31% | 6.59% | -46.51% | |
| Enterprise Value | 4,656 | 4,584 | 3,010 | 4,335 | 3,527 | 3,101 | |
| Last Close Price | 14.34 | 14.24 | 9.42 | 14.19 | 12.21 | 11.55 | |
| Forward PE | 44.35 | 59.68 | 87.63 | - | - | - | |
| PS Ratio | 7.11 | 6.95 | 5.33 | 10.42 | 10.42 | 10.53 | |
| PB Ratio | 16.25 | 16.06 | 14.51 | 25.98 | 27.88 | 10.47 | |
| P/TBV Ratio | 72.09 | 70.44 | - | - | - | 29.37 | |
| P/FCF Ratio | 151.01 | 147.56 | - | - | - | - | |
| P/OCF Ratio | 135.99 | 132.89 | - | - | - | - | |
| EV/Sales Ratio | 7.34 | 7.23 | 5.70 | 10.86 | 10.71 | 10.15 | |
| EV/EBITDA Ratio | 110.99 | 109.26 | 70.63 | - | - | - | |
| EV/EBIT Ratio | 135.00 | 132.89 | 88.35 | - | - | - | |
| EV/FCF Ratio | 156.00 | 153.56 | - | - | - | - | |
| Debt / Equity Ratio | 1.61 | 1.61 | 2.29 | 2.78 | 3.67 | 1.43 | |
| Debt / EBITDA Ratio | 8.73 | 8.73 | 8.61 | - | - | - | |
| Debt / FCF Ratio | 14.82 | 14.82 | - | - | - | - | |
| Net Debt / Equity Ratio | 0.54 | 0.54 | 1.00 | 0.99 | 1.29 | -0.14 | |
| Net Debt / EBITDA Ratio | 3.55 | 3.55 | 4.55 | -2.42 | -0.80 | 0.22 | |
| Net Debt / FCF Ratio | 4.99 | 4.99 | -5.17 | -2.08 | -0.93 | 0.21 | |
| Asset Turnover | 0.73 | 0.73 | 0.68 | 0.53 | 0.40 | 0.34 | |
| Inventory Turnover | 0.42 | 0.42 | 0.59 | 0.89 | 1.53 | 1.49 | |
| Quick Ratio | 1.72 | 1.72 | 2.36 | 2.23 | 2.59 | 3.67 | |
| Current Ratio | 2.84 | 2.84 | 3.39 | 2.88 | 3.05 | 4.09 | |
| Return on Equity (ROE) | -11.58% | -11.58% | -31.68% | -107.04% | -109.93% | -84.37% | |
| Return on Assets (ROA) | 2.48% | 2.48% | 2.72% | -6.12% | -15.68% | -13.95% | |
| Return on Invested Capital (ROIC) | -1176.15% | -1207.57% | 9.64% | -24.47% | -74.80% | -78.42% | |
| Return on Capital Employed (ROCE) | 4.80% | 4.80% | 5.40% | -12.00% | -34.90% | -26.30% | |
| Earnings Yield | -0.60% | -0.61% | -1.99% | -3.64% | -6.90% | -7.78% | |
| FCF Yield | 0.66% | 0.68% | -1.33% | -1.84% | -4.97% | -6.41% | |
| Buyback Yield / Dilution | -1.31% | -1.31% | -3.12% | -2.11% | -6.50% | -4.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.